Bing Xia
Impact in
- Molecular Biology top 0.5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- Cancer Research top 1%
Papers in
-
- DNA Repair Mechanisms 34
- CRISPR and Genetic Engineering 17
- RNA modifications and cancer 9
- Oncology 51
- Lung Cancer Research Studies 17
- Co-authors
- Masayori Inouye (9 shared papers)David M. Livingston (7 shared papers)Dima Kozakov (6 shared papers)Sándor Vajda (5 shared papers)Eileen White (3 shared papers)Jessie Yanxiang Guo (2 shared papers)Hong Cai (7 shared papers)Kathryn A. Porter (3 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Journal of Thoracic Oncology (7 papers)Cancer Research (6 papers)PLoS ONE (5 papers)Annals of Oncology (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bing Xia
258 papers receiving 10.1k citations
Bing Xia's Hit Papers
Peers
Comparison fields: 5 of 154
- Molecular Biology 6.6k
- Cancer Research 1.2k
- Genetics 2.3k
- Oncology 2.1k
- Immunology 650
Countries citing papers authored by Bing Xia
This map shows the geographic impact of Bing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xia more than expected).
Fields of papers citing papers by Bing Xia
This network shows the impact of papers produced by Bing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xia. The network helps show where Bing Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 270 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2 Hit paper breakdown → | 2006 | 646 |
| 2 | RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites Hit paper breakdown → | 2007 | 555 |
| 3 | Performance and Its Limits in Rigid Body Protein-Protein Docking Hit paper breakdown → | 2020 | 472 |
| 4 | New additions to the Hit paper breakdown → | 2016 | 424 |
| 5 | 2009 | 422 | |
| 6 | 2013 | 409 | |
| 7 | 2006 | 351 | |
| 8 | 2000 | 311 | |
| 9 | 2004 | 283 | |
| 10 | 2011 | 257 | |
| 11 | 2010 | 237 | |
| 12 | 2001 | 185 | |
| 13 | 2012 | 164 | |
| 14 | 2007 | 162 | |
| 15 | 2017 | 149 | |
| 16 | 2017 | 144 | |
| 17 | 2010 | 143 | |
| 18 | 1996 | 127 | |
| 19 | 2006 | 124 | |
| 20 | 2017 | 119 |
About Bing Xia
Bing Xia is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Surgery, having authored 270 papers that have together received 10.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (34 papers), Lung Cancer Treatments and Mutations (24 papers), BRCA gene mutations in cancer (21 papers), Lung Cancer Research Studies (17 papers), CRISPR and Genetic Engineering (17 papers), Inflammatory Bowel Disease (15 papers), Lung Cancer Diagnosis and Treatment (10 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Molecular Biology (6.6k citations), Cancer Research (1.2k citations), Genetics (2.3k citations), Oncology (2.1k citations) and Immunology (650 citations). Bing Xia has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Masayori Inouye, David M. Livingston, Dima Kozakov, Sándor Vajda, Eileen White, Jessie Yanxiang Guo, Hong Cai, Kathryn A. Porter, Haiping Ke and Tzeh Keong Foo. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancer Research, PLoS ONE and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.